Penumbra, Inc. to Present at Upcoming Investor Conferences
Penumbra (NYSE: PEN) has announced its upcoming participation in two major healthcare investor conferences. The company will present at the 2025 Wells Fargo Healthcare Conference on September 3, 2025, at 8:45 AM ET, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 1:50 PM ET.
Investors can access the presentation webcasts through Penumbra's website in the "Events and Presentations" section under the "Investors" tab. The recordings will remain available for a minimum of two weeks after each event.
Penumbra (NYSE: PEN) annuncia la partecipazione a due importanti conferenze per investitori nel settore sanitario. L'azienda presenterà al 2025 Wells Fargo Healthcare Conference il 3 settembre 2025 alle 08:45 ET e al Morgan Stanley 23rd Annual Global Healthcare Conference il 9 settembre 2025 alle 13:50 ET.
Gli investitori potranno seguire le webcast delle presentazioni sul sito di Penumbra, nella sezione "Eventi e Presentazioni" sotto la scheda "Investitori". Le registrazioni resteranno disponibili per almeno due settimane dopo ciascun evento.
Penumbra (NYSE: PEN) ha anunciado su participación en dos importantes conferencias para inversores del sector salud. La compañía presentará en la 2025 Wells Fargo Healthcare Conference el 3 de septiembre de 2025 a las 08:45 ET y en la Morgan Stanley 23rd Annual Global Healthcare Conference el 9 de septiembre de 2025 a la 13:50 ET.
Los inversores podrán acceder a las retransmisiones de las presentaciones en la web de Penumbra, en la sección "Eventos y Presentaciones" dentro de la pestaña "Inversores". Las grabaciones estarán disponibles como mínimo durante dos semanas después de cada evento.
Penumbra (NYSE: PEN)가 주요 헬스케어 투자자 컨퍼런스 두 곳에 참가할 예정이라고 발표했습니다. 회사는 2025 Wells Fargo Healthcare Conference에서 2025년 9월 3일 오전 8시 45분(ET)에, Morgan Stanley 23rd Annual Global Healthcare Conference에서 2025년 9월 9일 오후 1시 50분(ET)에 발표를 진행합니다.
투자자들은 Penumbra 웹사이트의 "이벤트 및 프레젠테이션" 섹션("투자자" 탭)에서 프레젠테이션 웹캐스트를 시청할 수 있습니다. 각 이벤트 후 녹화 영상은 최소 2주간 제공됩니다.
Penumbra (NYSE: PEN) a annoncé sa participation à deux grandes conférences pour investisseurs dans le secteur de la santé. La société présentera lors de la 2025 Wells Fargo Healthcare Conference le 3 septembre 2025 à 08h45 ET et lors de la Morgan Stanley 23rd Annual Global Healthcare Conference le 9 septembre 2025 à 13h50 ET.
Les investisseurs pourront accéder aux webcasts des présentations sur le site de Penumbra, dans la section « Événements et Présentations » sous l'onglet « Investisseurs ». Les enregistrements resteront disponibles pendant au moins deux semaines après chaque événement.
Penumbra (NYSE: PEN) hat seine Teilnahme an zwei wichtigen Healthcare-Investorenkonferenzen angekündigt. Das Unternehmen wird auf der 2025 Wells Fargo Healthcare Conference am 3. September 2025 um 08:45 Uhr ET und auf der Morgan Stanley 23rd Annual Global Healthcare Conference am 9. September 2025 um 13:50 Uhr ET präsentieren.
Investoren können die Webcasts der Präsentationen auf der Penumbra-Website in der Rubrik "Veranstaltungen und Präsentationen" unter dem Reiter "Investoren" abrufen. Die Aufzeichnungen sind jeweils mindestens zwei Wochen nach dem Event verfügbar.
- None.
- None.
Event: | 2025 Wells Fargo Healthcare Conference |
Date: | Wednesday, September 3, 2025 |
Time: | 8:45am ET/5:45am PT |
Event: | Morgan Stanley 23rd Annual Global Healthcare Conference |
Date: | Tuesday, September 9, 2025 |
Time: | 1:50pm ET/10:50am PT |
Webcasts of the presentations can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcasts will be available on the company's website for at least two weeks following each event.
About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.
Investor Relations
Penumbra, Inc.
investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-upcoming-investor-conferences-302532522.html
SOURCE Penumbra, Inc.